2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease.
Journal
Nature reviews. Cardiology
ISSN: 1759-5010
Titre abrégé: Nat Rev Cardiol
Pays: England
ID NLM: 101500075
Informations de publication
Date de publication:
Apr 2024
Apr 2024
Historique:
accepted:
13
09
2023
pubmed:
2
11
2023
medline:
2
11
2023
entrez:
2
11
2023
Statut:
ppublish
Résumé
Rheumatic heart disease (RHD) is an important and preventable cause of morbidity and mortality among children and young adults in low-income and middle-income countries, as well as among certain at-risk populations living in high-income countries. The 2012 World Heart Federation echocardiographic criteria provided a standardized approach for the identification of RHD and facilitated an improvement in early case detection. The 2012 criteria were used to define disease burden in numerous epidemiological studies, but researchers and clinicians have since highlighted limitations that have prompted a revision. In this updated version of the guidelines, we incorporate evidence from a scoping review, an expert panel and end-user feedback and present an approach for active case finding for RHD, including the use of screening and confirmatory criteria. These guidelines also introduce a new stage-based classification for RHD to identify the risk of disease progression. They describe the latest evidence and recommendations on population-based echocardiographic active case finding and risk stratification. Secondary antibiotic prophylaxis, echocardiography equipment and task sharing for RHD active case finding are also discussed. These World Heart Federation 2023 guidelines provide a concise and updated resource for clinical and research applications in RHD-endemic regions.
Identifiants
pubmed: 37914787
doi: 10.1038/s41569-023-00940-9
pii: 10.1038/s41569-023-00940-9
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
250-263Informations de copyright
© 2023. Springer Nature Limited.
Références
Watkins, D. A. et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N. Engl. J. Med. 377, 713–722 (2017).
pubmed: 28834488
doi: 10.1056/NEJMoa1603693
Francis, J. R. et al. Hyperendemic rheumatic heart disease in a remote Australian town identified by echocardiographic screening. Med. J. Aust. 213, 118–123 (2020).
pubmed: 32632952
doi: 10.5694/mja2.50682
Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685–694 (2005).
pubmed: 16253886
doi: 10.1016/S1473-3099(05)70267-X
Beaton, A. et al. Secondary antibiotic prophylaxis for latent rheumatic heart disease. N. Engl. J. Med. 386, 230–240 (2022).
pubmed: 34767321
doi: 10.1056/NEJMoa2102074
Watkins, D. A. et al. Rheumatic heart disease worldwide: JACC scientific expert panel. J. Am. Coll. Cardiol. 72, 1397–1416 (2018).
pubmed: 30213333
doi: 10.1016/j.jacc.2018.06.063
Roberts, K. V., Brown, A. D., Maguire, G. P., Atkinson, D. N. & Carapetis, J. R. Utility of auscultatory screening for detecting rheumatic heart disease in high-risk children in Australia’s Northern Territory. Med. J. Aust. 199, 196–199 (2013).
pubmed: 23909543
doi: 10.5694/mja13.10520
Reményi, B. et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease — an evidence-based guideline. Nat. Rev. Cardiol. 9, 297–309 (2012).
pubmed: 22371105
pmcid: 5523449
doi: 10.1038/nrcardio.2012.7
Beaton, A. et al. Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection. Pediatr. Cardiol. 35, 1259–1267 (2014).
pubmed: 24827080
doi: 10.1007/s00246-014-0925-3
Rémond, M. et al. Are minor echocardiographic changes associated with an increased risk of acute rheumatic fever or progression to rheumatic heart disease? Int. J. Cardiol. 198, 117–122 (2015).
pubmed: 26163902
doi: 10.1016/j.ijcard.2015.07.005
Nunes, M. C. P. et al. Simplified echocardiography screening criteria for diagnosing and predicting progression of latent rheumatic heart disease. Circ. Cardiovasc. Imaging 12, e007928 (2019).
pubmed: 30704283
doi: 10.1161/CIRCIMAGING.118.007928
Engelman, D. et al. Screening for rheumatic heart disease: quality and agreement of focused cardiac ultrasound by briefly trained health workers. BMC Cardiovasc. Disord. 16, 30 (2016).
pubmed: 26830341
pmcid: 4736281
doi: 10.1186/s12872-016-0205-7
Francis, J. R. et al. Single-view echocardiography by nonexpert practitioners to detect rheumatic heart disease: a prospective study of diagnostic accuracy. Circ. Cardiovasc. Imaging 14, e011790 (2021).
pubmed: 34384239
pmcid: 8373443
doi: 10.1161/CIRCIMAGING.120.011790
Beaton, A. et al. Task-shifting of handheld echocardiographic screening for rheumatic heart disease: longitudinal performance of non-experts in a school-based program. Glob. Heart 11, e19 (2016).
doi: 10.1016/j.gheart.2016.03.063
Pandian, N. G. et al. Recommendations for the use of echocardiography in the evaluation of rheumatic heart disease: a report from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 36, 3–28 (2023).
pubmed: 36428195
doi: 10.1016/j.echo.2022.10.009
Otto, C. M. et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143, e72–e227 (2021).
pubmed: 33332150
Vahanian, A. et al. ESC/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 43, 561–632 (2021).
doi: 10.1093/eurheartj/ehab395
Jacobs, A. K. et al. ACCF/AHA clinical practice guideline methodology summit report. Circulation 127, 268–310 (2013).
pubmed: 23230312
doi: 10.1161/CIR.0b013e31827e8e5f
Diamantino, A. et al. A focussed single-view hand-held echocardiography protocol for the detection of rheumatic heart disease. Cardiol. Young 28, 108–117 (2018).
pubmed: 28889812
doi: 10.1017/S1047951117001676
Beaton, A. et al. The utility of handheld echocardiography for early rheumatic heart disease diagnosis: a field study. Eur. Heart J. Cardiovasc. Imaging 16, 475–482 (2015).
pubmed: 25564396
pmcid: 4542771
doi: 10.1093/ehjci/jeu296
Lu, J. C. et al. Simplified rheumatic heart disease screening criteria for handheld echocardiography. J. Am. Soc. Echocardiogr. 28, 463–469 (2015).
pubmed: 25660669
doi: 10.1016/j.echo.2015.01.001
Remenyi, B. et al. Single parasternal-long-axis-view-sweep screening echocardiographic protocol to detect rheumatic heart disease: a prospective study of diagnostic accuracy. Heart Lung Circ. 29, 859–866 (2020).
pubmed: 31320258
doi: 10.1016/j.hlc.2019.02.196
Zühlke, L. J., Engel, M. E., Nkepu, S. & Mayosi, B. M. Evaluation of a focussed protocol for hand-held echocardiography and computer-assisted auscultation in detecting latent rheumatic heart disease in scholars. Cardiol. Young 26, 1097–1106 (2016).
pubmed: 26423122
doi: 10.1017/S1047951115001857
Beaton, A. et al. Improving the practicality of echocardiographic screening for rheumatic heart disease: performance of non-expert users following completion of a standardized computer-based training curriculum [abstract]. Circulation 132, A18811 (2015).
doi: 10.1161/circ.132.suppl_3.18811
Carapetis, J. R. et al. Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren. Nat. Clin. Pract. Cardiovasc. Med. 5, 411–417 (2008).
pubmed: 18398402
doi: 10.1038/ncpcardio1185
Bacquelin, R. et al. Echocardiography-based screening for rheumatic heart disease: what does borderline mean? Int. J. Cardiol. 203, 1003–1004 (2016).
pubmed: 26625330
doi: 10.1016/j.ijcard.2015.11.110
Scheel, A. et al. The inter-rater reliability and individual reviewer performance of the 2012 World Heart Federation guidelines for the echocardiographic diagnosis of latent rheumatic heart disease. Int. J. Cardiol. 328, 146–151 (2021).
pubmed: 33186665
doi: 10.1016/j.ijcard.2020.11.013
Engelman, D. et al. Focused cardiac ultrasound screening for rheumatic heart disease by briefly trained health workers: a study of diagnostic accuracy. Lancet Glob. Health 4, e386–e394 (2016).
pubmed: 27198843
doi: 10.1016/S2214-109X(16)30065-1
Francis, J. R. et al. Abbreviated echocardiographic screening for rheumatic heart disease by nonexperts with and without offsite expert review: a diagnostic accuracy study. J. Am. Soc. Echocardiogr. 36, 733–745 (2023).
pubmed: 36806665
doi: 10.1016/j.echo.2023.02.007
Webb, R. H. et al. Valvular regurgitation using portable echocardiography in a healthy student population: implications for rheumatic heart disease screening. J. Am. Soc. Echocardiogr. 28, 981–988 (2015).
pubmed: 25959548
doi: 10.1016/j.echo.2015.03.012
Clark, B. C. et al. Using a low-risk population to estimate the specificity of the World Heart Federation criteria for the diagnosis of rheumatic heart disease. J. Am. Soc. Echocardiogr. 29, 253–258 (2016).
pubmed: 26725186
doi: 10.1016/j.echo.2015.11.013
Roberts, K. et al. What is normal? Echocardiographic findings in low-risk children living in a region with high rates of rheumatic heart disease. Circulation 125, e723 (2012).
Remenyi, B. et al. Inter-rater and intra-rater reliability and agreement of echocardiographic diagnosis of rheumatic heart disease using the World Heart Federation evidence-based criteria. Heart Asia 11, e011233 (2019).
pubmed: 31297166
pmcid: 6591009
doi: 10.1136/heartasia-2019-011233
World Health Organization. Screening Programmes: A Short Guide. Increase Effectiveness, Maximize Benefits and Minimize Harm (WHO, 2020).
Beaton, A. et al. The utility of handheld echocardiography for early diagnosis of rheumatic heart disease. J. Am. Soc. Echocardiogr. 27, 42–49 (2014).
pubmed: 24183541
doi: 10.1016/j.echo.2013.09.013
Saxena, A. et al. Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation Monit Actuarial Trends Indian Child) study. Heart 97, 2018–2022 (2011).
pubmed: 22076022
doi: 10.1136/heartjnl-2011-300792
Nascimento, B. R. et al. Outcomes of echocardiography-detected rheumatic heart disease: validating a simplified score in cohorts from different countries. J. Am. Heart Assoc. 10, e021622 (2021).
pubmed: 34533041
pmcid: 8649515
doi: 10.1161/JAHA.121.021622
Bechtlufft, B. M. et al. Validation of a simplified score for predicting latent rheumatic heart disease progression using a prospective cohort of Brazilian schoolchildren. BMJ Open. 10, e036827 (2020).
pubmed: 32393615
pmcid: 7223287
doi: 10.1136/bmjopen-2020-036827
Alkhalifa, M., Ibrahim, S. & Osman, S. Pattern and severity of rheumatic valvular lesions in children in Khartoum, Sudan. East. Mediterr. Health J. 14, 1015–1021 (2008).
pubmed: 19161072
Saleh, H. K. Pattern of rheumatic heart disease in Southern Yemen. Saudi Med. J. 28, 108–113 (2007).
pubmed: 17206301
Aurakzai, H. A. et al. Echocardiographic profile of rheumatic heart disease at a tertiary cardiac centre. J. Ayub Med. Coll. Abbottabad 21, 122–126 (2009).
pubmed: 20929029
Sultan, F. et al. Rheumatic tricuspid valve disease: an evidence-based systematic overview. J. Heart Valve Dis. 19, 374–382 (2010).
pubmed: 20583402
Pettersen, M. D., Du, W., Skeens, M. E. & Humes, R. A. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J. Am. Soc. Echocardiogr. 21, 922–934 (2008).
pubmed: 18406572
doi: 10.1016/j.echo.2008.02.006
Lopez, L. et al. Relationship of echocardiographic Z scores adjusted for body surface area to age, sex, race, and ethnicity: the Pediatric Heart Network Normal Echocardiogram Database. Circ. Cardiovasc. Imaging 10, e006979 (2017).
pubmed: 29138232
pmcid: 5812349
doi: 10.1161/CIRCIMAGING.117.006979
Idsoe, O., Guthe, T., Willcox, R. & De Weck, A. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull. World Health Organ. 38, 159–188 (1968).
pubmed: 5302296
pmcid: 2554321
Sanyahumbi, A. et al. Penicillin reactions in patients with severe rheumatic heart disease: a presidential advisory from the American Heart Association. J. Am. Heart Assoc. 11, e024517 (2022).
pubmed: 35049336
pmcid: 9075066
doi: 10.1161/JAHA.121.024517
World Health Organization. Optimizing Active Case-Finding for Tuberculosis: Implementation Lessons from South-East Asia (WHO, 2021).
Thomas, R., Parikh, R., Paul, P. & Muliyil, J. Population-based screening versus case detection. Indian J. Ophthalmol. 50, 233–237 (2002).
pubmed: 12355704
Council of Europe. Committee of Ministers. Recommendations No. R (94) 11 on Screening as a Tool of Preventive Medicine. http://hrlibrary.umn.edu/instree/coerecr94-11.html (1994).
Wilson, J. M. G. & Junger, G. Principals and Practices of Screening for Diseases (WHO, 1968).
Roberts, K., Colquhoun, S., Steer, A., Reményi, B. & Carapetis, J. Screening for rheumatic heart disease: current approaches and controversies. Nat. Rev. Cardiol. 10, 49–58 (2013).
pubmed: 23149830
doi: 10.1038/nrcardio.2012.157
Gewitz, M. H. et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 131, 1806–1818 (2015).
pubmed: 25908771
doi: 10.1161/CIR.0000000000000205
Marijon, E. et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 357, 470–476 (2007).
pubmed: 17671255
doi: 10.1056/NEJMoa065085
Franco, J. et al. Investigation of the familial risk of rheumatic heart disease with systematic echocardiographic screening: data from the PROVAR+ family study. Pathogens 11, 139 (2022).
pubmed: 35215083
pmcid: 8877052
doi: 10.3390/pathogens11020139
Culliford-Semmens, N. et al. Echocardiography for latent rheumatic heart disease in first degree relatives of children with acute rheumatic fever: implications for active case finding in family members. eClinicalMedicine 37, 100935 (2021).
pubmed: 34386737
pmcid: 8343257
doi: 10.1016/j.eclinm.2021.100935
Aliku, T. et al. Targeted echocardiographic screening for latent rheumatic heart disease in Northern Uganda: evaluating familial risk following identification of an index case. PLoS Negl. Trop. Dis. 10, e0004727 (2016).
pubmed: 27294545
pmcid: 4905680
doi: 10.1371/journal.pntd.0004727
Nascimento, B. R. et al. Echocardiographic screening of pregnant women by non-physicians with remote interpretation in primary care: data from the PROVAR+ study. Circulation 140, A13370 (2019).
Manji, R. A. et al. Cost–effectiveness analysis of rheumatic heart disease prevention strategies. Expert Rev. Pharmacoecon. Outcomes Res. 13, 715–724 (2013).
pubmed: 24219047
doi: 10.1586/14737167.2013.852470
Essop, M. R. & Peters, F. Contemporary issues in rheumatic fever and chronic rheumatic heart disease. Circulation 130, 2181–2188 (2014).
pubmed: 25602946
doi: 10.1161/CIRCULATIONAHA.114.009857
Bradley-Hewitt, T. et al. The impact of echocardiographic screening for rheumatic heart disease on patient quality of life. J. Pediatr. 175, 123–129 (2016).
pubmed: 27268786
doi: 10.1016/j.jpeds.2016.04.087
Wark, E. K., Hodder, Y. C., Woods, C. E. & Maguire, G. P. Patient and health-care impact of a pilot rheumatic heart disease screening program. J. Paediatr. Child Health 49, 297–302 (2013).
pubmed: 23551836
doi: 10.1111/jpc.12154
Gurney, J. et al. The benefits and harms of rheumatic heart disease screening from the perspective of the screened population. Int. J. Cardiol. 221, 734–740 (2016).
pubmed: 27428313
doi: 10.1016/j.ijcard.2016.07.025
Zachariah, J. P. & Samnaliev, M. Echo-based screening of rheumatic heart disease in children: a cost–effectiveness Markov model. J. Med. Econ. 18, 410–419 (2015).
pubmed: 25629653
pmcid: 4497526
doi: 10.3111/13696998.2015.1006366
Roberts, K. et al. Echocardiographic screening for rheumatic heart disease in Indigenous Australian children: a cost–utility analysis. J. Am. Heart Assoc. 6, e004515 (2017).
pubmed: 28255077
pmcid: 5524001
doi: 10.1161/JAHA.116.004515
Vasan, R. S. et al. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation 94, 73–82 (1996).
pubmed: 8964121
doi: 10.1161/01.CIR.94.1.73
Ploutz, M. et al. Handheld echocardiographic screening for rheumatic heart disease by non-experts. Heart 102, 35–39 (2016).
pubmed: 26438784
doi: 10.1136/heartjnl-2015-308236
Peck, D. et al. The use of artificial intelligence guidance for rheumatic heart disease screening by novices. J. Am. Soc. Echocardiogr. 36, 724–732 (2023).
pubmed: 36906047
doi: 10.1016/j.echo.2023.03.001
Voleti, S. et al. Novel handheld ultrasound technology to enhance non-expert screening for rheumatic heart disease in the Republic of Palau: a descriptive study. J. Paediatr. Child Health 57, 1089–1095 (2021).
pubmed: 33624369
doi: 10.1111/jpc.15409
Beaton, A. et al. Efficacy of a standardized computer-based training curriculum to teach echocardiographic identification of rheumatic heart disease to nonexpert users. Am. J. Cardiol. 117, 1783–1789 (2016).
pubmed: 27084054
doi: 10.1016/j.amjcard.2016.03.006
Nascimento, B. R. et al. Integration of echocardiographic screening by non-physicians with remote reading in primary care. Heart 105, 283–290 (2019).
pubmed: 30181202
doi: 10.1136/heartjnl-2018-313593
Nascimento, B. R. et al. Rheumatic heart disease echocardiographic screening: approaching practical and affordable solutions. Heart 102, 658–664 (2016).
pubmed: 26891757
doi: 10.1136/heartjnl-2015-308635
Bhavnani, S. P. et al. A randomized trial of pocket-echocardiography integrated mobile health device assessments in modern structural heart disease clinics. JACC Cardiovasc. Imaging 11, 546–557 (2018).
pubmed: 28917688
doi: 10.1016/j.jcmg.2017.06.019
Martins, J. et al. Towards automatic diagnosis of rheumatic heart disease on echocardiographic exams through video-based deep learning. J. Am. Med. Inf. Assoc. 28, 1834–1842 (2021).
doi: 10.1093/jamia/ocab061
Nascimento, B. R. et al. Spatial-temporal deep-learning for automatic identification of rheumatic heart disease in echocardiographic screening images — data from the PROVAR-Atmosphere study [abstract]. J. Am. Coll. Cardiol. 77, 3243 (2021).
doi: 10.1016/S0735-1097(21)04597-6
Edwards, L. A. et al. Machine learning for pediatric echocardiographic mitral regurgitation detection. J. Am. Soc. Echocardiogr. 36, 96–104.e4 (2023).
pubmed: 36191670
doi: 10.1016/j.echo.2022.09.017
Engelman, D. et al. Teaching focused echocardiography for rheumatic heart disease screening. Ann. Pediatr. Cardiol. 8, 118–121 (2015).
pubmed: 26085762
pmcid: 4453179
doi: 10.4103/0974-2069.157024
Carapetis, J. R., McDonald, M. & Wilson, N. J. Acute rheumatic fever. Lancet 366, 155–168 (2005).
pubmed: 16005340
doi: 10.1016/S0140-6736(05)66874-2
Lawrence, J. G., Carapetis, J. R., Griffiths, K., Edwards, K. & Condon, J. R. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation 128, 492–501 (2013).
pubmed: 23794730
doi: 10.1161/CIRCULATIONAHA.113.001477
Bertaina, G. et al. Natural history of borderline rheumatic heart disease in New Caledonia: a prospective cohort study. Arch. Cardiovasc. Dis. Suppl. 9, 87 (2017).
Noubiap, J. J. et al. Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies. Sci. Rep. 9, 17022 (2019).
pubmed: 31745178
pmcid: 6863880
doi: 10.1038/s41598-019-53540-4
Beaton, A. et al. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation 125, 3127–3132 (2012).
pubmed: 22626741
doi: 10.1161/CIRCULATIONAHA.112.092312
Bhaya, M., Beniwal, R., Panwar, S. & Panwar, R. B. Two years of follow‐up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations. Echocardiography 28, 929–933 (2011).
pubmed: 21854437
doi: 10.1111/j.1540-8175.2011.01487.x
Zühlke, L. et al. The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study. BMC Cardiovasc. Disord. 16, 46 (2016).
pubmed: 26892774
pmcid: 4759741
doi: 10.1186/s12872-016-0225-3
Ploutz, M. et al. Child and teacher acceptability of school-based echocardiographic screening for rheumatic heart disease in Uganda. Cardiol. Young 27, 82–89 (2017).
pubmed: 26983378
doi: 10.1017/S1047951116000159
Perelini, F., Blair, N., Wilson, N., Farrell, A. & Aitken, A. Family acceptability of school-based echocardiographic screening for rheumatic heart disease in a high-risk population in New Zealand. J. Paediatr. Child Health 51, 682–688 (2015).
pubmed: 25756837
doi: 10.1111/jpc.12829
Voleti, S. et al. The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study. BMC Pregn. Childb. 20, 611 (2020).
doi: 10.1186/s12884-020-03189-z